Trial Profile
Effectiveness and safety of continuous administration of tolvaptan in the treatment of refractory congestive heart failure in a multicenter cohort study
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Jun 2013
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 26 Jun 2013 New trial record